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Abstract
Objective: To estimate the effectiveness of anterior cervical discectomy with arthroplasty (ACDA) compared to anterior
cervical discectomy with fusion (ACDF) for patient-important outcomes for single-level cervical spondylosis.
Data sources: Electronic databases (MEDLINE, EMBASE, Cochrane Register for Randomized Controlled Trials, BIOSIS and
LILACS), archives of spine meetings and bibliographies of relevant articles.
Study selection:We included RCTs of ACDF versus ACDA in adult patients with single-level cervical spondylosis reporting at
least one of the following outcomes: functionality, neurological success, neck pain, arm pain, quality of life, surgery for
adjacent level degeneration (ALD), reoperation and dysphonia/dysphagia. We used no language restrictions. We performed
title and abstract screening and full text screening independently and in duplicate.
Data synthesis: We used random-effects model to pool data using mean difference (MD) for continuous outcomes and
relative risk (RR) for dichotomous outcomes. We used GRADE to evaluate the quality of evidence for each outcome.
Results: Of 2804 citations, 9 articles reporting on 9 trials (1778 participants) were eligible. ACDA is associated with a clinically
significant lower incidence of neurologic failure (RR = 0.53, 95% CI = 0.37–0.75, p = 0.0004) and improvement in the Neck
pain visual analogue scale (VAS) (MD = 6.56, 95% CI = 3.22–9.90, p = 0.0001; Minimal clinically important difference (MCID)
= 2.5. ACDA is associated with a statistically but not clinically significant improvement in Arm pain VAS and SF-36 physical
component summary. ACDA is associated with non-statistically significant higher improvement in the Neck Disability Index
Score and lower incidence of ALD requiring surgery, reoperation, and dysphagia/dysphonia.
Conclusions: There is no strong evidence to support the routine use of ACDA over ACDF in single-level cervical spondylosis.
Current trials lack long-term data required to assess safety as well as surgery for ALD. We suggest that ACDA in patients with
single level cervical spondylosis is an option although its benefits and indication over ACDF remain in question.
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Introduction
Rationale
Cervical spondylosis is a common cause of radiculopathy and/
or myelopathy resulting in significant disability [1]. In patients that
do not respond adequately to conservative management, anterior
cervical discectomy with fusion (ACDF) is performed to achieve
neural decompression, maintain cervical lordosis and provide
segmental stabilization. ACDF halts neurological deterioration
and relieves radicular symptoms in patients with myelopathy and
radiculopathy, respectively. However, fusion results in increased
biomechanical forces at the adjacent (mobile) level and may thus
accelerate symptomatic degenerative progression [2]; some of
these patients may require further surgery at the adjacent level.
Anterior cervical discectomy with arthroplasty (ACDA) is an
alternative surgical option that could preserve segmental mobility
at the diseased level and theoretically decrease the incidence of
adjacent level degeneration (ALD). The key difference in this
procedure compared to an ACDF is a wider decompression (i.e.
generous bilateral foraminotomies) including resection of the
uncovertebral joints bilaterally. Further, patients are commonly
prescribed non-steroidal anti-inflammatory medication to prevent
heterotopic ossification in addition to postoperative pain control.
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Heterotopic ossification is most commonly described as a
complication of large joint arthroplasty and is the main cause of
the prosthesis to lose function [3]. Its prevalence in cervical
arthroplasty is 58.2% (95% CI =29.7–86.8%) 12 months after
surgery [3]. In addition, ACDA is a technically more difficult
operation to perform compared to an ACDF.
If ALD is truly decreased, this procedure may result in
decreased disability, decreased incidence of reoperation and
increased quality of life while achieving similar rates of neurolog-
ical success. If not, the use of ACDA increases health care costs
without any additional neurological benefit [4] and a potential of
greater harm if performed by a non-expert surgeon. Further, the
long-term risks associated with ACDA may not be as well
delineated compared to the more commonly performed ACDF.
Although several randomized clinical trials (RCTs) have
compared ACDF to A [5–9], it remains unclear whether ACDA
results in improved patient-important outco [4,10] and whether or
not its widespread use should be advocated. A systematic review
found that ACDA results in modest clinical benefits with respect to
neck pain, arm pain and quality of life compared to ACDF at
12 month follow-up, most of which were not sustained at 2 year
follow-up [4]. A recent review of 3 United States Food and Drug
Administration cervical arthroplasty trials concluded that ACDA
may be associated with a higher rate of neurological success and
lower prevalence of ALD 2 years following surgery [10].
There are no systematic reviews that have assessed publication
bias, evaluated the risk of bias of included trials, interpreted the
results with respect to clinical significance, evaluated the quality of
Figure 1. PRISMA 2009 Flow Diagram.
doi:10.1371/journal.pone.0043407.g001
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the evidence using the GRADE approach [11] (this is a systematic
and explicit method to evaluate the quality of the evidence), and
reported review findings in concordance with PRISMA guidelines
[12]. This review will improve upon the methodological short-
comings of the previous studies as well as include recently
published trials.
Objective
We systematically reviewed all randomized clinical trials
comparing the relative effects of ACDF to ACDA for single-level
cervical spondylosis on patient-important outcomes.
Methods
Protocol and registration
We developed a protocol prior to conduct of the review but did
not register it.
Eligibility criteria
Eligible studies had to include adult patients (greater than 50%
over 19 years of age at the time of inclusion), with single-level
cervical spondylosis (i.e. C3-T1) causing radiculopathy and/or
myelopathy, who have undergone single-level ACDF or ACDA.
Our outcomes of interest were the following: functionality, pain,
quality of life, surgery for ALD, reoperations, and dysphonia/
dysphagia. We only included RCTs. We excluded articles that
were duplicate reports of an earlier trial, post-hoc analysis of RCT
data or those in which we were unable to obtain the full-text
article.
Information sources
We searched MEDLINE (2002-January 2012), Embase (2002-
January 2012), Cochrane Central Register of Controlled Trials
(Issue 1 of 12, Jan 2012), BIOSIS (2002-January 2012) and
LILACS (2002-January 2012). We restricted the search to humans
and adults (19 years of age and older) but not to any specific
language(s). We limited the search to 2002 onwards because the
earliest trial included in a previously published systematic review
was published in 2004 [13]. We imported all search results into
Endnote X5 for removal of duplicates, and title and abstract
screening.
We hand searched reference lists of included articles and
conference abstracts for the 2011 AANS/CNS Section on
Disorders of the Spine and Peripheral Nerves and Eurospine
2011 meeting. We translated non-English papers. The first author
(A.F.) designed and conducted the search strategy with reference
to a systematic review on this topic [4] and reference to a highly
sensitive search strategy for identifying randomized trials [14].
Search
We used the following search terms in Ovid MEDLINE(R) and
Embase: ‘cervical spondylosis’, ‘cervical vertebrae’, ‘prosthesis’,
‘discectomy’, ‘arthroplasty’, ‘spinal fusion’, ‘randomized-controlled
trial’, ‘random allocation’ and ‘clinical trials’ (Appendix S1). We
used the term ‘‘cervical arthroplasty’’ to search the Cochrane
Central trials registry, BIOSIS and LILACS.
Figure 2. Neck disabiltiy index improvement in participants undergoing ACDA vs. ACDF for single level cervical spondylosis. CI
indicates confidence interval.
doi:10.1371/journal.pone.0043407.g002
Figure 3. Neurological success in participants undergoing ACDA vs. ACDF for single level cervical spondylosis. CI indicates confidence
interval.
doi:10.1371/journal.pone.0043407.g003
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Study selection
Title and abstract screening. Three reviewers (A.F., S.E.
and G.M.I.) screened independently and in duplicate, the title and
abstracts of identified citations for potential eligibility; we obtained
the full text of these citations.
Full text review. Using a standardized form, the same
reviewers independently and in duplicate applied the eligibility
criteria to full text articles. We checked agreement and resolved
disagreements through discussion. We calculated kappa scores to
measure the degree of agreement. If articles reported on the same
trial, we included the article with the most recent results or the
greater number of patients. We performed calibration exercises
and maintained a full list of excluded articles with reasons for
exclusion.
We performed title and abstract screening, full text review and
data abstraction in ‘RefWorks’ and ‘Endnote X5’ softwares.
Grading the quality of evidence. Two reviewers (A.F. and
G.M.I.) independently and in duplicate, applied GRADE to
eligible trials. The instructional manual in the ‘GRADEprofiler’
software version 3.6 was utilized to guide ratings. We downgraded
the quality of evidence only by 1 for each component. Risk of bias
was assessed as serious for subjective outcomes (i.e. neck pain and
arm pain) when blinding was not performed. Inconsistency was
determined by an I2 value of greater than 40% which could not be
explained by our predefined subgroup analysis. We marked down
for imprecision if the estimate crossed the nil effect point, unless
the 95% CI did not cross the MCID (for continuous outcomes).
We marked down for publication bias if this was suspected by
visual inspection of the funnel plot.
Data collection process
We developed and pilot-tested a data extraction form on an
electronic spreadsheet. One reviewer (A.F.) extracted data from
the included trials while a second reviewer (A.M.) checked the
extracted data for accuracy. We resolved disagreements through
discussion.
Data items
Reviewers extracted the following information from each
included trial: (1) characteristics of the trial (including number of
trial centers, year of trial, type of RCT, trial location, length of
follow-up and eligibility criteria); (2) characteristics of trial
participants (number and mean age of participants in each trial
arm); (3) name of prosthetic device utilized and whether the
surgical procedure was described; (4) Outcomes of interest; (5)
Cochrane risk of bias characteristics as well as other characteristics
that may lead to bias (A priori registration of protocol, expertise
based trial design, funding sources, method of statistical analysis
(i.e. intention to treat or per protocol analysis) and affiliation of the
authors with the medical device company).
Risk of bias in individual studies
To ascertain the validity of the included randomized trials,
reviewers independently determined the adequacy of randomiza-
tion; concealment of allocation; blinding of participants, providers,
Figure 4. Neck visual analogue scale pain score improvement in participants undergoing ACDA vs. ACDF for single level cervical
spondylosis. CI indicates confidence interval.
doi:10.1371/journal.pone.0043407.g004
Figure 5. Arm visual analogue pain score improvement in participants undergoing ACDA vs. ACDF for single level cervical
spondylosis. CI indicates confidence interval.
doi:10.1371/journal.pone.0043407.g005
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outcome assessors, data collectors and data analysts; the extent of
loss to follow-up; freedom from selective outcome reporting; and
freedom from other bias [15] (this was used to assess whether the
trial authors were affiliated or the trial was funded with the
prosthesis company) [16]. We used a ‘Modification of Cochrane
Tool to assess risk of bias in randomized trials’ where a forced
decision regarding bias must be made into ‘probably no’ or
‘probably yes’ for items that are thought to be of unclear risk
[17,18] (Appendix S1). We judged trials with more than 2 and
more than 4 high risk components as moderate risk and high risk,
respectively.
Summary measures
For continuous data, we calculated the pooled mean difference
(MD) and its 95% CI using the change from baseline scores,
standard deviation (SD) and total number of participants in each
treatment arm. If the SD was not reported, we imputed this from a
reported p value, confidence interval (CI) or standard error. In
cases where none of these were available, we used the mean SD
from other trials. For binary outcomes, we calculated the relative
risk (RR) and its 95% CI using the number of events and total
participants in each treatment arm. To facilitate interpretability,
we converted RR ratios to absolute risk reductions (ARR) and
number needed to treat (NNT). We selected values for minimal
clinically important differences (MCID) through a literature
review. MCID values were selected based on the methodological
rigour of the study and the similarity of the patients to this review.
Planned method of analysis
Any kind of variability across trials in a systematic review is
termed heterogeneity. Variability may result from clinical diversity
(i.e. the participants or interventions differ across trials) or
methodological diversity (i.e. methodological design and risk of
biases differ across trials). When the statistical tests for heteroge-
neity (variability in the treatment effects between trials) is
significant, this is unlikely to be attributed to chance alone [19].
We explored heterogeneity using the I2 statistic. This statistic aims
to assess the impact of the heterogeneity on the meta- analysis
[19]. We considered an I2 score of 0% to 40% as ‘‘heterogeneity
might not be important’’; 30% to 60% as ‘‘may represent
moderate heterogeneity*; 50% to 90% as ‘‘may represent
substantial heterogeneity’’ and; 75% to 100% as ‘‘considerable
heterogeneity’’ [19]. We explored heterogeneity greater than 30%
by performing a priori specified subgroup analyses: type of
prosthesis used and the length of follow-up (24 months versus less
than 24 months). We utilized a random effects (inverse variance)
model to account for heterogeneity amongst trials.
Risk of bias across studies
We assessed the possibility of publication bias by evaluating
funnel plots. A funnel plot is a scatter plot of the intervention effect
estimates from individual trials against a measure of its precision
[20]. In the absence of publication bias, the plot will resemble an
inverted funnel. Although there are several reasons for asymmetric
funnel plots, its presence generally indicates publication bias or is
due to exaggeration of treatment effects in small, low quality trials
[20].
Additional analyses
We performed sensitivity analyses for any continuous outcome
with a statistically significant result (and greater than the MCID
where applicable) for which SD was estimated; in these cases, we
assumed the highest and lowest SD from other trials to determine
the robustness of our conclusions.
Figure 6. SF-36 physical component summary score improvement in participants undergoing ACDA vs. ACDF for single level
cervical spondylosis. CI indicates confidence interval.
doi:10.1371/journal.pone.0043407.g006
Figure 7. Surgery for ALD in participants undergoing ACDA vs. ACDF for single level cervical spondylosis. CI indicates confidence
interval.
doi:10.1371/journal.pone.0043407.g007
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Results
Study selection
Figure 1 illustrates the study flow. We identified a total of 9
articles reporting on 9 trials (1778 participants) for inclusion
(Table 1). Appendix S1 presents the list of excluded articles with
reasons for exclusion. We achieved excellent agreement for
screening of full text articles (Kappa = 0.92, SE 0.08; 95% CI
= 0.78–1.07).
Study characteristics
Tables 1 and Figure 11 present the study and participant
characteristics of the included trials.
Risk of bias within studies
Appendix S1 presents the Cochrane risk of bias assessment of
the included articles. There were 3 trials with high risks of bias
[20–22], 3 trials with moderate risk of bias [5,23,24], and 3 trials
with low risk of bias [6,25,26] (Appendix S1).
Results of individual studies and synthesis of results
Functionality. Six trials consisting of 1147 pariticpants report
on NDI change (continuous outcome) following surgery to
measure functionality. We imputed the SD using the p value in
1 trial [23], the 95% CI in 1 trial [5], the SD of baseline and end
scores in 3 trials [22,25,26] and the mean SD in 1 trial [6]. Pooled
analysis shows that ACDA is associated with a greater improve-
ment in NDI compared to ACDF: MD (95% CI) = 3.03 (20.16 to
6.21), p = 0.06 (Figure 2). The upper and lower limits of the CI are
smaller than the minimally clinically important difference (MCID)
of 7.5 [27] and 8.5 [28] identified in the literature. There is
considerable heterogeneity (I2 = 76%) which can not be explained
using our predefined subgroup analysis. The quality of evidence
for this outcome is low.
Neurological Success. Five trials consisting of 1409 partic-
ipants report on neurological success (dichotomous outcome).
Pooled analysis shows that ACDA is associated with a higher
incidence of neurological success compared to ACDF: RR (95%
CI) = 0.53 (0.37 to 0.75), p = 0.0004 (Figure 3). Heterogeneity
amongst the trials might not be important (I2 = 0%). This
translates into an ARR of 5.8% (NNT =17). The quality of
evidence for this outcome is moderate.
Neck pain. Six trials consisting of 1168 participants report on
neck pain using the Visual Analogue Scale (VAS) (continuous
outcome). We imputed unreported SD using the 95% CI in 1 trial
[5], the SD of baseline and end scores in 2 trials [22,24] and the
mean SD in 3 trials [6,23,25]. One trial reports neck and arm pain
together [25]. Pooled analysis shows that ACDA is associated with
a greater improvement in neck pain compared to ACDF: MD
(95% CI) = 6.56, (3.22 to 9.90), p = 0.0001 (Figure 4). This effect is
greater than the MCID of 2.5 [27]. There is moderate
heterogeneity (I2 = 79%) which can not be explained using our
predefined subgroup analysis. The quality of evidence for this
outcome is very low.
Arm pain. Seven trials consisting of 1188 paritcipants report
on arm pain using the VAS (continuous outcome). The SD was
imputed using the 95% CI in 1 trals [5], the SD of baseline and
end scores in 2 trials [24,26] and the mean SD in 3 trials [6,23,25].
One trial reports neck and arm pain together [25]. Pooled analysis
shows that ACDA is associated with a greater improvement in arm
pain on the VAS compared to ACDF: MD (95% CI) = 2.88 (0.63
to 5.12), p = 0.01 (Figure 5). However, the 95% CI of the summary
effect crosses the MCID threshold of 2.5 [27]. Heterogeneity
Figure 8. Reoperation in participants undergoing ACDA vs. ACDF for single level cervical spondylosis. CI indicates confidence interval.
doi:10.1371/journal.pone.0043407.g008
Figure 9. Dysphonia/dysphagia in participants undergoing ACDA vs. ACDF for single level cervical spondylosis. CI indicates
confidence interval.
doi:10.1371/journal.pone.0043407.g009
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amongst the trials might not be important (I2 = 0%). The quality
of evidence for this outcome is low.
Quality of life. Two trials consisting of 590 participants
report on the SF-36 physical component score (PCS) change
(continuous outcome) following surgery to measure quality of life.
The SD is not available in one trial but was estimated using the SD
in the other trial [23]. Pooled analysis shows that ACDA is
associated with a greater improvement in SF-36 PCS compared to
ACDF: MD (95% CI) = 2.28 (0.40 to 4.17), p = 0.02 (Figure 6).
However, the 95% CI of the summary effect spans the MCID
threshold of 4.1 [27]. Heterogeneity amongst the trials might not
be important (I2 = 0%). The quality of evidence for this outcomes
is moderate.
Surgery for adjacent level disease. Four trials consisting of
1446 participants report data on surgery for ALD (dichotomous
outcome). Pooled analysis shows that participants that undergo an
ACDA are at a non-statistically significant lower risk to undergo
surgery for ALD in comparison to those that undergo ACDF: RR
(95% CI) = 0.80 (0.45 to 1.41) p= 0.43 (Figure 7). This translates
to an ARR of 1.2% (NNT =83). Heterogeneity amongst the trials
might not be important (I2 = 18%). The quality of evidence for this
outcome is low.
Reoperation. Four trials consisting of 1448 participants
reported on reoperation (dichotomous outcome). Pooled analysis
shows that participants that undergo an ACDA are at a non-
statistically significant lower risk to undergo a reoperation in
comparison to those that undergo ACDF: RR (95% CI) = 0.71
(0.36 to 1.39) p = 0.32 (Figure 8). This translates to an ARR of
1.4% (NNT =71). Heterogeneity amongst the trials might not be
important (I2 = 27%). The quality of evidence for this outcome is
low.
Dysphonia/Dysphagia. Three trials consisting of 802 par-
ticipants report on surgery for dysphonia/dysphagia. The trial by
McAfee et al. only includes participants with dysphagia [20].
Pooled analysis shows that participants that undergo an ACDA are
at a non-statistically significant lower risk to develop dyphagia/
dyphonia in comparison to those that undergo ACDF: RR (95%
CI) = 0.68 (0.34 to 1.33), p = 0.26 (Figure 9). This translates to an
ARR of 1.3% (NNT =77). Heterogeneity amongst the trials may
be moderate (I2 = 43%) and is not explained using our predefined
subgroup analysis. The quality of evidence for this outcome is very
low.
Risk of bias across studies
The trials generally had a high risk of bias for lack of blinding
and affiliation with the sponsoring implant manufacturing
company, moderate risk of bias for poor allocation concealment,
lack of blinding of outcome assessors and selective reporting bias,
and low risk of bias for randomization sequence generation and
incomplete outcome data (Figure 10). Due to the small number of
trials for each outcome, we could not reliably detect publication
bias. However, funnel plots were assymmetric, raising suspicion for
publication bias, for ALD requiring surgery and reoperation.
Additional analysis
Sensitivity analysis. Statistical heterogeneity for functional-
ity is eliminated if the trial by Wang et al. is removed. This is the
only Chinese trial and only trial that favours ACDF for
functionality. Removal of this trial still results in no clinically
significant improvement in functionality in comparison to ACDF.
Sensitivity analysis assuming the highest and lowest SD for
estimated SD data for Neck pain VAS score improvement results
in a MD (95% CI) = 6.52, (3.24 to 9.80), p,0.0001 and MD (95%
CI) = 6.58, (3.08 to 10.07), p = 0.0002, respectively. The upper
and lower threshold of the 95% CI under both assumptions is still
greater than the MCID threshold of 2.5 [27].
Discussion
Summary and quality of evidence using GRADE
ACDA is associated with a clinically significant greater
improvement in neck pain and higher incidence of neurologic
success. ACDA is associated with a statistically significant but not
clinically significant greater improvement in arm pain and quality
of life. ACDA is associated with a non-statistically significant
greater improvement in functionality, and lower incidence of ALD
requiring surgery, reoperation and dysphagia/dysphonia. The
quality of evidence was assessed using GRADE (Figure 11).
Neck pain and neurological success. It is unclear why
ACDA results in a greater improvement in neck pain and
neurological success as these are thought to be related to adequate
neural decompression and stabilization, respectively. Perhaps, a
wider lateral decompression that is required for ACDA results in a
greater amount of neural decompression; this is irrespective of the
spacer device used. The greater neurological success and
decreased neck pain associated with ACDA should be cautiously
interpreted given that the patients and outcome assessors were
generally not blinded [4].
Figure 10. Cochrane risk of bias across studies.
doi:10.1371/journal.pone.0043407.g010
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Functionality and surgery for adjacent level
degeneration. The two most critical outcomes when consider-
ing the use of ACDA over ACDF is functionality and surgery for
ALD. We obtained adequate power to conclude that there is no
clinically important benefit of ACDA over ACDF. We were
underpowered to determine whether ACDA results in a lower
incidence of surgery for ALD. The point estimate equates to a
NNT of 83. The NNT for the lower boundary of the CI equates to
37 corresponding to the most benefit one would expect to obtain.
However, there are two important caveats: 1) ALD is a time
Figure 11. Grade profile for ACDA vs. ACDF for single level cervical spondylosis.
doi:10.1371/journal.pone.0043407.g011
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dependent complication requiring studies of longer follow-up
duration to determine any benefit for ACDA. Interestingly, the
trial by Coric et al [6] that most strongly favoured ACDF is also
the one with the shortest followup duration (i.e. 24 months)
(Figure 7). A hypothesis for future studies is that any benefits of
ACDA over ACDF in preventing ALD may be better appreciated
in the long-term; and 2) None of the trials defined the criteria for
surgical intervention for ALD a priori. Given the paucity of long-
term data, there is no evidence that ACDA results in increased
complications compared to ACDF. Therefore, ACDA remains an
option for symptomatic single-level spondylosis.
Comparison to other systematic reviews/meta-analysis
There are several systematic reviews and meta-analyses on this
topic, some suggesting a clinical benefit of ACDA over ACDF
[21,29–32] while others suggested no clinical benefit of ACDA
over ACDF [4,33]. However, these systematic reviews suffer from
a number of methodological limitations. Only two reviews
searched for non-English articles [4,13] and only one translated
non-English articles [13]. There is evidence that trials with positive
results are more likely to be published in English language journals
[34]. This is particularly relevant as the only trial that found
greater NDI improvement in the ACDF arm was the Chinese trial
by Wang et al [22].
Cepoui-Martin et al. only qualitatively described the data [33]
due to methodological flaws and poor reporting of the original
trials. Although this, more conservative, approach may be
appropriate, we obtained enough information and imputed data
when it was unavailable to perform a meta-analysis. We tested our
assumptions using sensitivity analysis. The authors of this review
conclude moderate to strong evidence supporting the efficacy of
ACDA but are not transparent on how GRADE was applied to
formulate these recommendations. This is important as the
application of GRADE has a subjective component. We graded
the quality of evidence as ‘very low’ to ‘moderate’ and were
transparent about our decision-making (Figure 11).
Yu et al. pooled trial results using fixed effects and concluded
that neurological success, repeat operation and neck pain favour
ACDA [32]. Random effects were only utilized when I2 was
greater than 50%. Since we are pooling results from several
prosthetic devices which are thought to work through different
mechanisms, it is much more likely that the underlying effect is not
fixed and therefore a more conservative, random effects model
should be utilized.
Two reviews quantitatively pooled trials to enhance power for
obtaining a statistically significant result without conducting
systematic searches [21,31]. Authors from one of these reviews
had a priori knowledge that all selected trials favoured arthroplasty
[21]. This approach is extremely susceptible to providing
misleading results. In this review, NDI success is defined as a
greater than 15 point increase; no reference is provided for a
scientific basis of choosing this threshold [21].
We agree with Botelho et al. that there is a paucity of data
regarding the incidence of ALD with ACDA [13]. Most trials
report ALD requiring surgery which may be prone to bias if the
criteria for ALD surgery are not defined a priori. The systematic
review by Jiang et al. conclude that there is a lower rate of ALD
surgery with ACDA [30]. However, they have included a non-
randomized study [35] in their analysis, whose removal would lead
to a borderline significant result.
Strengths
There are several strengths to this meta-analysis including a
rigorous search strategy, no language limitations, article screening
and methodological assessments performed in duplicate, abstract-
ed data verified by a second reviewer and utilization of the
GRADE approach to summarize findings and judge the quality of
evidence. In addition, this is the first systematic review on this
topic to incorporate MCID in interpreting findings. This approach
focuses on clinically important differences as opposed to statisti-
cally important differences.
Limitations
There are several limitations to this meta-analysis: 1) There is a
variable length of follow-up across trials. This is particularly
important for evaluating surgery for ALD as this outcome is time-
dependent; 2) There may be a prosthetic device that is superior to
others with respect to functionality and decreased incidence of
ALD. Combining data across trials may fail to identify this; 3)
Reporting quality was generally poor across trials; therefore, it is
unclear if a lack of difference between the 2 interventions is due to
poor methodological quality of the trial or a true lack of difference
in effect; and 4) We were unable to obtain data for several relevant
abstracts that we identified despite contacting authors.
Ongoing studies
We identified several ongoing trials pertaining to this topic:
DISCOVERTM (NCT00432159, NCT00735176), GRANVIAH-
C (NCT01518582), Mobi-C (NCT00554528) and The Neo-
DiscTM (NCT00478088). The eventual addition of these trials to
the current body of evidence is likely to improve our confidence in
the conclusions and ability to make informed treatment recom-
mendations.
Conclusions
Implications for practice. We suggest that ADCA in adult
patients with single level cervical spondylosis is an option. The
indication and benefits over ACDF remain in question. In
addition, long-term safety data of this device is not available.
We invite clinicians to consider patient’s values and preferences in
selecting the surgical treatment.
Implications for research. The quality of current evidence
varied from ‘very low’ to ‘moderate’ (Figure 11). Future trials
should register their protocols, not be funded or clearly be
independent from influence by implant manufacturing companies
[15], be adequately powered to assess all patient important
outcomes, utilize an expertise-based design, safeguard against
biases, centrally adjudicate indications for surgery for ALD and
reoperation, fully account for all trial participants and report long-
term follow-up utilizing the CONSORT guidelines.
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